Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.75 and traded as high as $3.28. Sonoma Pharmaceuticals shares last traded at $3.24, with a volume of 63,393 shares traded.
Sonoma Pharmaceuticals Price Performance
The stock has a 50 day moving average of $2.92 and a 200 day moving average of $2.75. The firm has a market cap of $5.24 million, a P/E ratio of -0.81 and a beta of 1.66.
About Sonoma Pharmaceuticals
Sonoma Pharmaceuticals, Inc, develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, Asia, and internationally. The company offers Regenacyn, a prescription scar gel; Pediacyn, a pediatric dermatology and wound care product for over-the-counter (OTC) use; Epicyn, an Antimicrobial Facial Cleanser; Levicyn, an HOCl based prescription and OTC product to use and relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis.
Read More
- Five stocks we like better than Sonoma Pharmaceuticals
- Compound Interest and Why It Matters When Investing
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- 3 Dividend Kings To Consider
- What Ray Dalio’s Latest Moves Tell Investors
- ESG Stocks, What Investors Should Know
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for Sonoma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonoma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
